Literature DB >> 15220442

RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system.

Matthew J Evans1, Eran Bacharach, Stephen P Goff.   

Abstract

Encapsidation of the Moloney murine leukemia virus (MMLV) genome is mediated through a specific interaction between the major viral structural protein, Gag, and an RNA packaging signal, Psi. Many studies have investigated this process in vivo, although the specific examination of the Gag-RNA interaction in this context is difficult due to the variety of other viral functions involved in virion assembly in vivo. The Saccharomyces cerevisiae three-hybrid assay was used to directly examine the interaction between MMLV Gag and Psi. In this system, MMLV RNA regions exhibiting high-affinity Gag binding were mapped. All Gag-binding regions were located 3' to the viral splice donor sequence of the viral RNA transcript. No single short RNA sequence within Psi supported strong Gag interaction. Instead, an RNA comprised of nearly the entire Psi region was necessary to demonstrate an appreciable Gag interaction in the yeast three-hybrid system. These finding support the notion that two stem-loops (C and D) are not sufficient to form a core MMLV encapsidation signal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220442      PMCID: PMC434088          DOI: 10.1128/JVI.78.14.7677-7684.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  RNA packaging.

Authors:  R Berkowitz; J Fisher; S P Goff
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

2.  A three-hybrid system to detect RNA-protein interactions in vivo.

Authors:  D J SenGupta; B Zhang; B Kraemer; P Pochart; S Fields; M Wickens
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Dimerization of MoMuLV genomic RNA: redefinition of the role of the palindromic stem-loop H1 (278-303) and new roles for stem-loops H2 (310-352) and H3 (355-374).

Authors:  M De Tapia; V Metzler; M Mougel; B Ehresmann; C Ehresmann
Journal:  Biochemistry       Date:  1998-04-28       Impact factor: 3.162

4.  A role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions.

Authors:  M Mougel; E Barklis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA.

Authors:  M Mougel; Y Zhang; E Barklis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.

Authors:  E g Lee; A Yeo; B Kraemer; M Wickens; M L Linial
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.

Authors:  Y Shi; K Alin; S P Goff
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

8.  Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.

Authors:  R D Berkowitz; J Luban; S P Goff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Binding of the human immunodeficiency virus type 1 Gag protein to the viral RNA encapsidation signal in the yeast three-hybrid system.

Authors:  E Bacharach; S P Goff
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses.

Authors:  K Alin; S P Goff
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

View more
  7 in total

1.  Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome.

Authors:  Cristina Gherghe; Tania Lombo; Christopher W Leonard; Siddhartha A K Datta; Julian W Bess; Robert J Gorelick; Alan Rein; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

2.  An immature retroviral RNA genome resembles a kinetically trapped intermediate state.

Authors:  Jacob K Grohman; Robert J Gorelick; Sumith Kottegoda; Nancy L Allbritton; Alan Rein; Kevin M Weeks
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

3.  Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity.

Authors:  Michal Mark-Danieli; Nihay Laham; Michal Kenan-Eichler; Asher Castiel; Daniel Melamed; Meytal Landau; Nicole M Bouvier; Matthew J Evans; Eran Bacharach
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 4.  Development and clinical translation of ex vivo gene therapy.

Authors:  Xiaomo Wu; Xiaorong He; Fahui Liu; Xiaochang Jiang; Ping Wang; Jinyan Zhang; Ju Jiang
Journal:  Comput Struct Biotechnol J       Date:  2022-06-11       Impact factor: 6.155

5.  Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domain.

Authors:  Cristina Gherghe; Christopher W Leonard; Robert J Gorelick; Kevin M Weeks
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

6.  Inferring Protein Function in an Emerging Virus: Detection of the Nucleoprotein in Tilapia Lake Virus.

Authors:  Reem Abu Rass; Talia Kustin; Rachel Zamostiano; Nechama Smorodinsky; Daniella Ben Meir; Daniel Feder; Nischay Mishra; W Ian Lipkin; Avi Eldar; Marcelo Ehrlich; Adi Stern; Eran Bacharach
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

Review 7.  NMR Studies of Retroviral Genome Packaging.

Authors:  Patricia S Boyd; Janae B Brown; Joshua D Brown; Jonathan Catazaro; Issac Chaudry; Pengfei Ding; Xinmei Dong; Jan Marchant; Colin T O'Hern; Karndeep Singh; Canessa Swanson; Michael F Summers; Saif Yasin
Journal:  Viruses       Date:  2020-09-30       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.